Investors Buy Large Volume of Aurora Cannabis Call Options (NASDAQ:ACB)

Aurora Cannabis Inc. (NASDAQ:ACB) saw some unusual options trading activity on Wednesday. Stock traders acquired 14,617 call options on the company. This represents an increase of 230% compared to the typical volume of 4,428 call options.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Cubist Systematic Strategies LLC bought a new stake in shares of Aurora Cannabis during the second quarter worth $50,000. Cetera Advisors LLC bought a new stake in shares of Aurora Cannabis during the first quarter worth $59,000. Toronto Dominion Bank grew its stake in shares of Aurora Cannabis by 34,356.4% during the second quarter. Toronto Dominion Bank now owns 18,951 shares of the company’s stock worth $88,000 after buying an additional 18,896 shares during the last quarter. Concurrent Investment Advisors LLC bought a new stake in shares of Aurora Cannabis during the first quarter worth $90,000. Finally, Baader Bank Aktiengesellschaft grew its stake in shares of Aurora Cannabis by 121.1% during the second quarter. Baader Bank Aktiengesellschaft now owns 22,789 shares of the company’s stock worth $100,000 after buying an additional 12,481 shares during the last quarter. 47.63% of the stock is owned by institutional investors.

Aurora Cannabis Stock Down 3.1 %

NASDAQ ACB opened at $5.91 on Thursday. The company has a current ratio of 3.76, a quick ratio of 2.03 and a debt-to-equity ratio of 0.08. Aurora Cannabis has a 1-year low of $2.84 and a 1-year high of $9.35. The company has a 50 day moving average of $5.85 and a 200-day moving average of $6.05. The company has a market cap of $322.37 million, a price-to-earnings ratio of -4.36 and a beta of 1.86.

Aurora Cannabis (NASDAQ:ACB) last announced its quarterly earnings data on Wednesday, August 7th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.24. The business had revenue of $67.27 million for the quarter, compared to analysts’ expectations of $55.98 million. Aurora Cannabis had a negative net margin of 14.46% and a negative return on equity of 7.00%. On average, equities research analysts expect that Aurora Cannabis will post -0.37 earnings per share for the current fiscal year.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.